Abstract
Formation of meningiomas has been associated with the loss of genetic material on chromosome 22. To approach the additional chromosomal events that underlie progression of these tumors to malignancy, we have examined several other chromosomal regions for loss of heterozygosity (LOH) in these tumors. Fifty-eight tumors, comprising 43 benign meningiomas, 11 atypical meningiomas and four malignant meningiomas, were examined. While the loss of chromosome 22 was seen in approximately half of all these tumors, regardless of their malignancy, the most frequent chromosomal losses observed in the malignant and atypical tumors were on the long arm of chromosome 14. Thirty-nine tumors were informative for at least one of the three markers on chromosome 14 that we tested. Of these, 7/14 malignant and atypical tumors showed LOH in contrast to only 1/25 benign tumors. Other loci that showed LOH in malignant tumors, although at a much lower frequency, were on chromosomes 17p and 1p. The high frequency of LOH for loci on chromosome 14q in atypical and malignant tumors suggests the presence of a tumor progression gene at this locus. In one of the malignant meningiomas heterozygosity was lost at D14S13 and D14S16 but retained at the proximal marker D14S43 as well as the more distal marker D14S23. This suggests that an interstitial deletion occurred in this tumor which should be useful for further refining the position of the putative tumor progression locus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Menon, A., Rutter, J., von Sattel, J. et al. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus. Oncogene 14, 611–616 (1997). https://doi.org/10.1038/sj.onc.1200853
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1200853
Keywords
This article is cited by
-
Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis
Journal of Neuro-Oncology (2022)
-
Emerging glioneuronal and neuronal tumors: case-based review
Brain Tumor Pathology (2022)
-
Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation
Oncogene (2013)
-
MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas
Journal of Neuro-Oncology (2013)
-
Molecular and genetic profiles of radiographically defined de novo meningiomas
Journal of Neuro-Oncology (2012)